Hiroto Hatakeyama

10PUBLICATIONS
17CO-AUTHORS
AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsNanometrologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 04, 2026
Antibody therapeutics with high affinity for FcγRs exacerbate anaphylaxis via FcγR-mediated capture by tumor-associated myeloid cells.

Ruiheng Tang, Aizemaiti Aibai, Yuta Tamemoto

|Jan 28, 2026
Photothermal Therapy-Induced Immunogenic Cell Death Synergistically Enhances the Therapeutic Effect of Immune Checkpoint Inhibitors.

Shogo Yasuda, Yui Horikawa, Mei Ohashi

|Feb 24, 2024
The Effect of Cholesterol Content on the Adjuvant Activity of Nucleic-Acid-Free Lipid Nanoparticles.

Jessica Anindita, Hiroki Tanaka, Takuma Yamakawa

|Dec 23, 2023
Development of a Ready-to-Use-Type RNA Vaccine Carrier Based on an Intracellular Environment-Responsive Lipid-like Material with Immune-Activating Vitamin E Scaffolds.

Jessica Anindita, Hiroki Tanaka, Ryotaro Oyama

|Dec 21, 2022
Tumor-associated neutrophils and macrophages exacerbate antidrug IgG-mediated anaphylactic reaction against an immune checkpoint inhibitor.

Takahiro Arai, Tomomi Kokubo, Ruiheng Tang

|Mar 10, 2022
Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell-specific liposomal siRNA delivery system.

Nako Maishi, Yu Sakurai, Hiroto Hatakeyama

Pageof 2

Frequent Collaborators

3 joint publications

Yu Sakurai

2 joint publications

Hiromi Sato

2 joint publications

Hidetaka Akita

1 joint publications

Yoshihiro Onouchi